UNICHEM LABORATORIES LIMITED

Press Releases Unichem Laboratories Limited

Equities

UNICHEMLAB

INE351A01035

Delayed Bombay S.E. Other stock markets 06:07:22 13/05/2024 BST			5-day change	1st Jan Change
562.4 ^INR	-0.65%		-0.27%	+38.22%

03-29	Unichem Laboratories Limited Announces Board Resignations, Effective March 31, 2024	CI
03-27	Unichem Laboratories Chief Commercial and International Business Development Officer Steps Down	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Unichem Laboratories : Disclosure on ESOP 2023	07/09/23	PU
Unichem Laboratories : Newspaper advertisement for Notice of 60th Annual General Meeting and Remote E-Voting	31/08/23	PU
Unichem Laboratories : Draft Annual Return 2022-23	31/08/23	PU
Unichem Laboratories : Newspaper advertisement for Notice to the Members of the 60th Annual General Meeting through Video Conference (‘VC’)/ Other Audio Visual Means (‘OVAM’)	23/08/23	PU
Unichem Laboratories : Annual Report – 2022-23	22/08/23	PU
Unichem Laboratories : News paper Publication of Financial Results for quarter ended 30.6.2023	17/07/23	PU
Unichem Laboratories : Unaudited Results (Consolidated and Standalone) Quarter year ended June 30, 2023	14/07/23	PU
Unichem Laboratories : Federal Circuit Crystallizes BMS' Apixaban District Court Win	28/09/21	AQ
Unichem Laboratories : Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015	12/07/21	AQ
Unichem Laboratories : Tentative Approval for ANDA from United States Food and Drug Administration (USFDA) for Sitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg.	10/07/21	PU
Unichem Laboratories : ANDA approval from United States Food and Drug Administration for Unichem's Zonisamide Capsules, USP 25 mg, 50 mg and 100 mg	28/01/21	AQ
Unichem Laboratories : Certificate under regulation 74(5) of the SEBl (Depositories and Participants) Regulations. 2018 for the quarter ended December 31, 2020.	14/01/21	PU
Unichem Laboratories Limited : - ANDA Approval from USFDA for Unichem's Amiodarone Tablets	23/07/20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer